Expression of interleukin-1 beta, tumor necrosis factor alpha, interleukins-6, 10 and 4, and metalloproteases by freshly isolated mononuclear cells from carly never- treated and non acute-treated rheumatoid arthritis patients
Vazquez-Del Mercado M, Delgado-Rizo V, Munoz-Valle JF +2 more1999Clinical & Experimental Rheumatology, Sept –Oct
Immune/InnateMusculoskeletal
Summary
No abstract is available for this paper. It was published in Clinical & Experimental Rheumatology, Sept –Oct in 1999 by Vazquez-Del Mercado M and colleagues. CIRS Nexus tags it under Immune/Innate, Musculoskeletal.
Part of CIRS Nexus · Curated by Lauren Lowenstein, The Biotoxin Lady
Key Biomarkers
Interleukin-1 betaInterleukin-10Interleukin-4Interleukin-6MetalloproteasesTumor necrosis factor-alpha
Related Papers
- Pro-resolving and anti-arthritic properties of the MC1 selective agonist PL8177Frontiers in Immunology · 2022 · 2 shared tags
- A Transcriptomic Fingerprint for Parkinson's Disease Found in Patients with Chronic Inflammatory Response Syndrome: Implications for Diagnosis, Treatment and PreventionMedical Research Archives · 2024 · 2 shared tags
- Inflammation and osteosarcopeniaOsteosarcopenia · 2022 · 2 shared tags
- A Narrative Review of the Immunomodulatory Effects of Acthar® Gel Beyond Its Steroidogenic PropertiesAdvances in Therapy · 2025 · 2 shared tags
- Phytoplankton Toxins and Their Potential Therapeutic Applications: A Journey toward the Quest for Potent PharmaceuticalsMarine Drugs · 2022 · 2 shared tags
- Challenges in tolerogenic dendritic cell therapy for autoimmune diseases: the route of administrationImmunotherapy Advances · 2023 · 2 shared tags